|
The manufacturer was notified of the explant of a perceval plus size xl valve.The following provides a summary of all information currently available to the manufacturer from the healthcare facility.On (b)(6)2026, an aortic valve replacement surgery was conducted using a perceval plus heart valve size xl.In the post-operative period, the patient developed hypotension and acidosis.During the echocardiogram (echo) evaluation performed after the procedure, it was observed that the valve had displaced from its original position causing a severe aortic regurgitation, and the non-coronary leaflet of the valve showed an anomalous behaviour.The patient was taken back to the operating room the same day for reoperation to explant the valve.During the intraoperative assessment, the perceval valve was explanted and examined for potential reimplantation.The explanted valve was attempted to be collapsed and difficulties were encountered as they were not able to fit the valve properly into the delivery system.As a result, the valve was successfully replaced with another new perceval plus size xl valve.
|
|
The manufacturing and material records for the device involved in this event, as they pertain to the reported issue, were retrieved and reviewed by the manufacturer¿s quality engineering.The results confirmed that this prosthesis satisfied all required material, visual, and performance standards at the time of manufacture and release.A follow-up report will be submitted upon completion of device investigation and/or availability of new information.
|